ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Biejiajian Pill Inhibits Carcinogenesis and Metastasis via the Akt/GSK-3β/Snail Signaling Pathway in Hepatocellular Carcinoma

Sun, Jialing; Chen, Weicong; Wen, Bin; Zhang, Mingjia; Sun, Haitao; Yang, Xuemei; Zhao, Wenting; La, Lei; An, Haiyan; Pang, Jie; Gao, Lei*; He, Songqi*南方医科大学
Frontiers in Pharmacology2021-3-8DOI: 10.3389/fphar.2021.610158
8被引10阅读
引用收藏
分享

摘要

Hepatocellular carcinoma (HCC) is among the most usual cancers globally. In China, Biejiajian pill (BJJP), Traditional Chinese Medicine clinical prescription, is broadly utilized for the prevention and therapy of HCC. However, the mechanisms by which BJJP exerts its effects on the prevention of tumor invasion and metastasis are still largely unknown. In this study, in vitro multiple hepatic cancer cell lines and an in vivo xenograft mice model were used to validate the preventive effects and molecular mechanisms of BJJP in HCC. We established that BJJP significantly repressed the proliferation, metastasis and infiltration of HCC cells. Furthermore, BJJP remarkably suppressed HCC cell migration, as well as invasion via epithelial-mesenchymal transition (EMT) by modulating Snail expression, which was associated with the repression of Akt/GSK-3 beta/Snail signaling axis activation. In vivo HCC xenograft results indicated that BJJP delayed HCC development and efficiently inhibited lung metastasis. Taken together, BJJP was shown to be an effective therapeutic agent against HCC through repression of the Akt/GSK-3 beta/Snail signaling cascade and EMT.

学科与关键词

关键词
hepatocellular carcinomabiejiajian pilltraditional Chinese medicineakt/GSK-3 beta/Snail signaling pathwayepithelial-mesenchymal transition
相关
加载中…
  • Biejiajian pill inhibits progression of hepatocellular carcinoma by downregulating PDGFRO signaling in cancer-associated fibroblasts
    Chen, Weicong; Yang, Xuemei; Sun, Jialing; Chen, Yuyao; Zhao, Wenting; He, Chunyu; An, Haiyan; Pang, Jie; Xu, Wei; Wen, Bin*; Sun, Haitao*; He, Songqi*Journal of Ethnopharmacology, 2023, 301: 115825.被引 1
  • Biejiajian Pill Promotes the Infiltration of CD8+ T Cells in Hepatocellular Carcinoma by Regulating the Expression of CCL5
    Yang, Xuemei; Sun, Jialing; Wen, Bin; Wang, Yu; Zhang, Mingjia; Chen, Weicong; Zhao, Wenting; He, Chunyu; Zhong, Xiaodan; Liu, Yang; Li, Tong; Sun, Haitao*; He, Songqi*Frontiers in Pharmacology, 2021, 12: 771046.被引 4
  • Traditional Chinese medicine formulation Yanggan Jiedu Sanjie inhibits TGF-β1-induced epithelial-mesenchymal transition and metastatic potential in human hepatocarcinoma Bel-7402 cells.
    Hu, Bing*; An, Hong-Mei; Yan, Xia; Zheng, Jia-Lu; Huang, Xiao-Wei; Li, MiaoBMC Complement Altern Med, 2019, 19(1): 67.
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Pharmacology
发表日期
2021-03-08
卷期
第 12 卷
页码
610158
DOI
10.3389/fphar.2021.610158
语言
ENGLISH
期刊收录
NSL
期刊等级
2区
成果收录
SCIE
资助标注
Natural Science Foundation of Guangdong Province [81573808, 81774037, 81774170, 82074131]; [2018B030306012]

作者

  • S

    Sun, Jialing (第一作者)

    southern med univ

  • C

    Chen, Weicong

    southern med univ

查看全部 12 位作者收起作者
  • W

    Wen, Bin

  • Z

    Zhang, Mingjia

    southern med univ

  • S

    Sun, Haitao

    southern med univ

  • Y

    Yang, Xuemei

    southern med univ

  • Z

    Zhao, Wenting

    southern med univ

  • L

    La, Lei

    southern med univ

  • A

    An, Haiyan

    southern med univ

  • P

    Pang, Jie

    southern med univ

  • G

    Gao, Lei (通讯)

    southern med univ

  • H

    He, Songqi (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417